Correction to Lancet Neurol 2019; 18: 748–59

Donners SJA, van Velzen TJ, Cheng SF, et al. Optimised medical therapy alone versus optimised medical therapy plus revascularisation for asymptomatic or low-to-intermediate risk symptomatic carotid stenosis (ECST-2): 2-year interim results of a multicentre randomised trial. Lancet Neurol 2025; 24: 389–99—in the appendix of this Article, the names of the two investigators from France have been corrected. These corrections have been made as of Jan 21, 2026.